通过B细胞急性淋巴细胞白血病利用纤维溶解系统及其治疗向
Valentina R Minciacchi1, Jimena Bravo2, Christina Karantanou3
1Center for Thrombosis and Hemostasis (CTH), Johannes Gutenberg University Medical Center, 55131, Mainz, Germany.
Nature communications
|November 20, 2024
概括
附录A2的等离子激活通过改变骨髓微环境影响B细胞急性淋巴细胞白血病 (B-ALL).
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 纤维解,血块的分解,对于造血干细胞的动员至关重要.
- 骨髓微环境 (BMM) 在白血病进展中起着至关重要的作用.
研究的目的:
- 调查附录A2 (ANXA2) 激活等离子体在B细胞急性淋巴细胞白血病 (B-ALL) 进展中的作用.
- 了解BMM中的纤维解和细胞外矩阵 (ECM) 重塑如何影响B-ALL生长.
主要方法:
- 研究了ANXA2,等离子体和B-ALL中的BMM之间的相互作用.
- 分析了ECM密度和胰岛素样生长因子 (IGF) 1信号对B-ALL增殖的影响.
- 评估了使用e-aminocaproic acid (EACA) 抑制等离子体激活的治疗潜力.
主要成果:
- 降低等离子体活性导致密集的ECM捕获IGF1,减少B-ALL的增殖.
- B-ALL诱导肝脏等离子素的产生,增加等离子素的活性.
- 在B-ALL模型中,EACA治疗降低了瘤负担和延长了存活时间,与纤维素蛋白增加有关.
- 人类数据显示在B-ALL活检中,IGF1和纤维素蛋白水平之间存在相关性.
结论:
- 纤维解析介导的ECM重塑和生长因子释放显著影响B-ALL进展.
- 通过EACA抑制等离子体激活显示出作为B-ALL.的辅助治疗的前景.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K